Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.

Trial Phase 4 Completed March 22, 2026

Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis

Trial N/A Not yet recruiting March 22, 2026

"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"

Trial N/A Not yet recruiting March 22, 2026

Targeting Apathy With Music in Parkinson's Disease

Trial N/A Recruiting March 22, 2026

Early Parkinson's Disease Monotherapy With CVN424

Trial Phase 2 Completed March 22, 2026

Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life

Trial N/A Recruiting March 22, 2026

Microbiome and Diet in Parkinson's Disease

Trial N/A Recruiting March 22, 2026

Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome

Trial N/A Completed March 22, 2026

Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis

Trial N/A Active, not recruiting March 19, 2026

LFP-based Parameter Prediction in DBS for Parkinson's Disease

Trial N/A Recruiting March 19, 2026

Effectiveness of Online Program and Task-related Training for Parkinson's Disease

Trial N/A Recruiting March 19, 2026

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Trial Phase 1 Recruiting March 19, 2026

A Study to Evaluate Temporary Blood Brain Barrier Disruption in Patients With Parkinson's Disease Dementia

Trial N/A Completed March 19, 2026

PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia

Trial N/A Active, not recruiting March 19, 2026

A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD

Trial N/A Completed March 19, 2026

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Trial N/A Recruiting March 19, 2026

Effects Of Strategy Training And PNF On Balance, Gait, And Independence In Parkinson's Disease

Trial N/A Not yet recruiting March 19, 2026

Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

Trial N/A Completed March 19, 2026

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease

Trial N/A Recruiting March 19, 2026

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease

Trial N/A Completed March 19, 2026